Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma

European Journal of Haematology

Volumn 81, Issue 5, 2008, Pages 374-379

  Strasser Weippl, Kathrin ^a   Ludwig, Heinz ^a  

^a WILHELMINEN HOSPITAL   (Austria)

Author keywords

Multiple myeloma; Prognosis; Quality of life

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; CALCIUM; CREATININE; HEMOGLOBIN; LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COGNITION; DISEASE ACTIVITY; EMOTION; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; PAIN ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSOCIAL ENVIRONMENT; QUALITY OF LIFE; RATING SCALE; SOCIAL ASPECT; SYMPTOMATOLOGY; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ALBUMINS; ATTITUDE TO HEALTH; BETA 2-MICROGLOBULIN; CALCIUM; CREATININE; DISEASE-FREE SURVIVAL; EMOTIONS; FEMALE; HEMOGLOBINS; HUMANS; L-LACTATE DEHYDROGENASE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; SOCIAL CHANGE; SURVIVAL RATE;

EID: 54249101808     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2008.01126.x     Document Type: Article

References (19)

1. Brenner H, Gondos A, Pulte D. Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood 2008 111 : 2521 6.
2. Gulbrandsen N, Hjermstad MJ, Wisloff F. Interpretation of quality of life scores in multiple myeloma by comparison with a reference population and assessment of the clinical importance of score differences. Eur J Haematol 2004 72 : 172 80.
3. Wisloff F, Gulbrandsen N. Health-related quality of life and patients' perceptions in interferon-treated multiple myeloma patients. Nordic Myeloma Study Group. Acta Oncol 2000 39 : 809 13.
4. Wisloff F, Hjorth M. Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 1997 97 : 29 37.
5. Dubois D, Dhawan R, Van de Velde H, Esseltine D, Gupta S, Viala M, de la LC. Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma. J Clin Oncol 2006 24 : 976 82.
6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993 85 : 365 76.
7. King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996 5 : 555 67.
8. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J. Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 1994 3 : 353 64.
9. Ludwig H, Spicka I, Klener P, et al. Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma. Br J Haematol 2005 131 : 329 37.
10. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Using reference data on quality of life - the importance of adjusting for age and gender, exemplified by the EORTC QLQ-C30 (+3). Eur J Cancer 1998 34 : 1381 9.
11. Gulbrandsen N, Wisloff F, Brinch L, et al. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support. Med Oncol 2001 18 : 65 77.
12. Wisloff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P. Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes. Eur J Haematol 2005 75 : 293 8.
13. Rehse B, Pukrop R. Effects of psychosocial interventions on quality of life in adult cancer patients: meta analysis of 37 published controlled outcome studies. Patient Educ Couns 2003 50 : 179 86.
14. Tamburini M, Brunelli C, Rosso S, Ventafridda V. Prognostic value of quality of life scores in terminal cancer patients. J Pain Symptom Manage 1996 11 : 32 41.
15. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989 2 : 888 91.
16. Fawzy FI, Canada AL, Fawzy NW. Malignant melanoma: effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up. Arch Gen Psychiatry 2003 60 : 100 3.
17. Linn MW, Linn BS, Harris R. Effects of counseling for late stage cancer patients. Cancer 1982 49 : 1048 55.
18. Goodwin PJ, Leszcz M, Ennis M, et al. The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med 2001 345 : 1719 26.
19. Coyne JC, Stefanek M, Palmer SC. Psychotherapy and survival in cancer: the conflict between hope and evidence. Psychol Bull 2007 133 : 367 94.